Search

Matthew Levengood Phones & Addresses

  • 2108 237Th St SE, Bothell, WA 98021
  • Redmond, WA
  • Madison, WI
  • Urbana, IL
  • 16 Wylks Dr, Douglassville, PA 19518 (610) 326-1056
  • Champaign, IL

Work

Company: Seattle genetics Mar 2019 Position: Principal scientist, protein sciences

Education

Degree: Doctorates, Doctor of Philosophy School / High School: University of Illinois at Urbana - Champaign 2003 to 2008 Specialities: Chemistry

Industries

Biotechnology

Resumes

Resumes

Matthew Levengood Photo 1

Principal Scientist, Protein Sciences

View page
Location:
Bothell, WA
Industry:
Biotechnology
Work:
Seattle Genetics
Principal Scientist, Protein Sciences

Seattle Genetics
Senior Scientist, Chemistry

Seattle Genetics Jul 1, 2011 - Sep 2015
Research Scientist, Chemistry

University of Wisconsin-Madison Dec 2008 - Jun 2011
Postdoctoral Fellow
Education:
University of Illinois at Urbana - Champaign 2003 - 2008
Doctorates, Doctor of Philosophy, Chemistry
Elizabethtown College 1999 - 2003
Bachelors, Bachelor of Science, Chemistry

Publications

Us Patents

Cd47 Antibodies And Uses Thereof For Treating Cancer

View page
US Patent:
20190185561, Jun 20, 2019
Filed:
Nov 29, 2018
Appl. No.:
16/203809
Inventors:
- Bothell WA, US
Matthew Levengood - Bothell WA, US
Vivian Trang - Lynnwood WA, US
Lori Westendorf - Bothell MA, US
Christopher Carosino - Duvall WA, US
Michael Feldhaus - Boston MA, US
Assignee:
Seattle Genetics, Inc. - Bothell WA
International Classification:
C07K 16/28
A61P 35/00
Abstract:
Humanized antibodies, including masked antibodies that specifically bind to CD47 are provided. Methods for using anti-CD47 antibodies, including masked antibodies, to modulate activity of (e.g., inhibit proliferation of) a CD47-expressing cell, as well as for the treatment of one or more diseases or disorders (e.g., cancer) associated with CD47-expressing cells, are provided.
Matthew Roy Levengood from Bothell, WA, age ~44 Get Report